Cost Estimate of Immune-Related Adverse Reactions Associated with Innovative Treatments of Metastatic Melanoma
ConclusionThis study may represent a useful tool to understand the economic burden associated with the management of irAEs associated with patients affected by metastatic melanoma.
Source: Clinical Drug Investigation - Category: Drugs & Pharmacology Source Type: research
More News: Cancer & Oncology | Epidemiology | Italy Health | Melanoma | Skin Cancer | Study | UK Health | Yervoy